Literature DB >> 17827256

Molecular transduction mechanisms of cytokine-hormone interactions: role of gp130 cytokines.

Juan Gerez1, José Bonfiglio, Sebastian Sosa, Damiana Giacomini, Matias Acuña, Alberto Carbia Nagashima, Marcelo J Perone, Susana Silberstein, Ulrich Renner, Günter K Stalla, Eduardo Arzt.   

Abstract

Highly sophisticated mechanisms confer on the immune system the capacity to respond with a certain degree of autonomy. However, the final outcome of an immune response depends on the interaction of the immune system with other systems. The immune and neuroendocrine systems have an intimate cross-communication that makes possible a satisfactory response to environmental changes. Part of this interaction occurs through cytokines and steroid hormones. The last step of this cross-talk is the molecular level. As a model of interaction, this review focuses on the gp130 cytokine family. These cytokines, as well as their receptors, are expressed in pituitary cells. They regulate hormone production as well as growth of pituitary cells. During acute or chronic inflammation or infection, systemic, hypothalamic and hypophyseal gp130 cytokines act on anterior pituitary cells, integrating the neuroendocrine-immune response. Disruptions of these pathways may lead not only to abnormal growth of pituitary cells but also to immune disorders, for which, based on recent findings, targeting these cytokines might be a novel therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827256     DOI: 10.1113/expphysiol.2007.036236

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  1 in total

1.  Molecular characterization and expression analysis of the putative interleukin 6 receptor (IL-6Rα and glycoprotein-130) in rainbow trout (Oncorhynchus mykiss): salmonid IL-6Rα possesses a polymorphic N-terminal Ig domain with variable numbers of two repeats.

Authors:  Maria M Costa; Tiehui Wang; Milena M Monte; Christopher J Secombes
Journal:  Immunogenetics       Date:  2011-10-29       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.